DIJANA STJEPANOVIC: Open Payments
NPI 1861894164 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$993 in 44 payments from 24 companies in 2025. Trend: 2023 $1,692 · 2024 $1,534 · 2025 $993
Food & beverage: $993
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 7 | $231 |
| GENZYME CORPORATION | 3 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| Gilead Sciences, Inc. | 3 | $51 |
| ABBVIE INC. | 3 | $50 |
| Merck Sharp & Dohme LLC | 2 | $48 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| Incyte Corporation | 2 | $39 |
| Caris MPI, Inc. | 2 | $38 |
Products named: OJJAARA, SARCLISA, JEMPERLI, Trodelvy, KEYTRUDA, OPDIVO, KISQALI, MI CANCER SEEK.
Industry payments across MI — which companies pay providers there.
